When Silence

Tinnitus Research Map

Choose a hypothesis and step into its universe: the researchers, treatments, evidence and trials that surround it

Early human evidenceEnter

Acoustic Shock Syndrome

Human study (non-randomized / first-in-human)

Some people exposed to a sudden acoustic shock (a brief, unexpected loud sound, e.g. a tone burst through a call-centre headset) develop a lasting cluster of symptoms, tinnitus, hyperacusis, a feeling of fullness or tension in the ear, dizziness, and pain in and around the ear, that ordinary hearing tests can't explain. This hypothesis proposes that the trigger is not the inner ear but a tiny middle-ear muscle, the tensor tympani, and the trigeminal nerve system it feeds into: overuse and injury of that muscle spark inflammation that drives the whole symptom cluster. Because that circuit runs in both directions, the same wiring may be why neck injuries (whiplash) or jaw problems can also trigger ear symptoms, and vice versa.

312
Early human evidenceEnter

Central Gain

Human study (non-randomized / first-in-human)

When the ear is damaged and sends fewer signals to the brain, the central auditory system turns up its own amplification, its 'central gain', to keep its average activity stable, so that as the ear delivers less, activity in the central auditory brain paradoxically increases. The compensation is genuinely useful and can even restore basic hearing. But turning up the amplifier also amplifies the system's own background noise, and when it overshoots the result is sound that isn't there (tinnitus) and everyday sounds that feel unbearably loud (hyperacusis), and this can happen even when a standard hearing test looks perfectly normal ('hidden hearing loss'). In animals, perceived loudness and sound-evoked brain activity even rose in lockstep, direct evidence that the turned-up gain is what makes sounds too loud.

1148
Early human evidenceEnter

Central Neuroinflammation

Human study (non-randomized / first-in-human)

This hypothesis proposes that tinnitus is driven not only by altered neural firing but by an immune response inside the brain itself. After hearing loss, the auditory cortex's resident immune cells (microglia) switch on and release the inflammatory signalling molecule TNF-α, which retunes cortical synapses, strengthening excitation and weakening inhibition, until the circuit tips into the hyperexcitable state heard as phantom sound. The evidence is unusually direct: in mice, deleting or blocking TNF-α prevents tinnitus, depleting microglia prevents it too, and simply infusing TNF-α into the auditory cortex creates tinnitus in animals with perfectly normal hearing, showing the inflammation is a cause, not just a bystander. In people the evidence is so far correlational: a meta-analysis of nearly thirty studies finds TNF-α and IL-1β elevated with microglia and astrocytes activated, and biomarker studies show inflammatory molecules tracking tinnitus. Because it points to an off-the-shelf class of drugs, anti-inflammatories and TNF-α blockers, this account also carries a clear therapeutic implication.

836
Early human evidenceEnter

Cochlear Synaptopathy

Human study (non-randomized / first-in-human)

Loud noise and ordinary aging can silently sever the connections between the ear's sensory hair cells and the auditory nerve fibers that carry sound to the brain, well before the hair cells themselves die or hearing thresholds rise on a standard test. Remarkably, a noise exposure that produces only a 'temporary', fully-recovering threshold shift can still leave this nerve damage permanently in place. Because thresholds look normal, this damage is 'hidden hearing loss', and human temporal-bone studies confirm the same silent nerve loss occurs with ordinary aging, likely contributing to the common complaint of struggling to hear in noisy places even when a hearing test comes back clean.

4255
Early human evidenceEnter

Cortical Tonotopic Map Reorganization

Human study (non-randomized / first-in-human)

The auditory cortex is normally laid out like a map, with neighboring patches of tissue tuned to neighboring sound frequencies. This hypothesis proposes that after hearing loss, the patch that would normally respond to the now-silent frequencies doesn't stay quiet, neurons at its edge shift their tuning inward and take over the vacated territory, which becomes both over-represented and hyperactive. In humans, the size of this map distortion tracks directly with how loud the tinnitus feels. But a large, more recent study complicates the story: cortical map changes seem to track the amount of hearing loss more than the presence of tinnitus itself, suggesting reorganization may be as much a signature of the underlying damage as a direct cause of the phantom sound.

7616
Clinically testedEnter

Dorsal Cochlear Nucleus Origin

Randomized controlled trial (human)

This hypothesis places the origin of tinnitus in the dorsal cochlear nucleus (DCN), the first brainstem station of the auditory pathway. After hearing damage, the DCN's output neurons (fusiform cells) begin firing too much and too synchronously, and this hypersynchronous activity is thought to be the neural 'code' the rest of the brain reads as a phantom sound. Tellingly, the same ear damage produces tinnitus in only some animals, those whose fusiform cells develop this synchrony, which pins the difference on the brainstem rather than the ear. What tips the DCN into that state is maladaptive auditory, somatosensory integration (fusiform cells combine sound with head-and-neck sensation), and that is also the therapeutic lever: precisely-timed bimodal stimulation reversed tinnitus in a human randomized trial, though the timing is critical, mistime the sound-and-touch pairing and the benefit disappears.

132598
Early human evidenceEnter

Interacting Brain Networks

Human study (non-randomized / first-in-human)

This hypothesis says tinnitus is not produced by one damaged spot. The sound you hear is an emergent property of several brain networks running in parallel: a minimal 'tinnitus core' that makes the sound conscious at all, plus separate networks that add its loudness, which ear it seems to come from, and the distress it causes. These networks talk to each other at shared hubs, each using its own brain rhythm. Underneath it, loss of input shifts the thalamus, cortex loop out of its normal idling rhythm, and the brain fills the missing information in from memory and prediction, which is what gets heard. Strikingly, a machine-learning classifier found the same rhythm signature across tinnitus, pain, Parkinson's and depression: the same mechanism, differing mainly in where it sits. Fear and distress are not a side effect bolted onto an otherwise purely auditory signal: connectivity from the amygdala (the brain's fear hub) to the auditory cortex is abnormally strong in tinnitus and tracks directly with how distressing it feels, while the Default Mode Network and the insula-centered Salience Network both show altered connectivity that scales with tinnitus severity, naming the specific networks behind why tinnitus so often brings anxiety and unshakeable attention along with it.

14739
PreclinicalEnter

Potassium Channel Dysfunction

Animal study (in vivo)

This hypothesis traces tinnitus to a specific molecular switch: Kv7.2/3 (KCNQ2/3) potassium channels, which normally act as a brake holding down the excitability of neurons in the dorsal cochlear nucleus. After noise exposure, this brake weakens in essentially every exposed animal, but only the animals that fail to restore it within about a week go on to develop tinnitus; those that recover it become resilient instead. Because Kv7 channels are already a validated drug target for epilepsy, this mechanism comes with a built-in therapeutic strategy: small molecules that reopen Kv7 channels prevented tinnitus in mice, even when given a full week after the noise injury, and the same channel class is the target of Kv7-opener drugs (including XEN1101/Azetukalner) already in human development for other conditions.

6135
PreclinicalEnter

PV Interneuron Dysfunction

Animal study (in vivo)

Parvalbumin-expressing (PV) inhibitory interneurons act as a gain-control 'volume knob' in the auditory cortex, a single cell type that sets how strongly the brain amplifies sound. When they hypofunction after peripheral injury, cortical circuits become hyperactive, driving loudness hypersensitivity (hyperacusis) and tinnitus-related percepts. Remarkably, just a few minutes of stimulating these cells at 40 Hz reversed hyperacusis for about a week in mice, and only 40 Hz worked, not 1 Hz or 70 Hz, suggesting the therapy speaks the cells' own natural rhythm.

4115